Companies in the oncology sector developing innovative solutions and technologies.
Explore 311 recently funded oncology companies with verified founder contact information and fundraising data.
Yomi Pharma is a biotech company that focuses on developing innovative therapeutic solutions for oncology.
ImmunityBio is a late-stage immunotherapy startup that is developing treatments to drive immunogenic pathways in the fight against cancer.
Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.
Patient-centric cancer data and analytics platform for translational cancer biologists
Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.
Hula Therapeutics is a pediatric oncology company.
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
AdvanCell develops targeted alpha radiopharmaceutical therapies for cancer and supports their development and manufacturing.
Publicly traded (RKV.V) company focused on the development of new cancer treatments based on novel DNA-damage response technologies.
Apmonia Therapeutics is a biotech company that develop therapeutic strategies towards multiple types of cancer.
Erasca is a developer of oncology drugs intended to provide precision oncology options.
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
Autem Therapeutics is an oncology therapeutic and bioelectric technology company which provides cancer care.
Liminatus Pharma is a immuno‑oncology company offering CD47‑blockade antibody solutions to prevent anemia and thrombocytopenia.
Incanthera develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific
Alnair Therapeutics is a preclinical stage precision oncology platform focusing on developing innovative approaches to treat difficult.
Medicenna is a clinical stage, privately held, immuno-oncology company.
Siren Biotechnology focuses on combining AAV gene therapy with cytokine immunotherapy to develop innovative treatments for cancer.
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
xCures is a SaaS platform that aggregates, organizes and structures EMRs providing multimodal data across all diseases.
Thalia Therapeutics is a drug reformulation company.
DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.
The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 311 oncology companies tracked in the VCBacked database.
Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked